Programme


SCIENTIFIC PROGRAMME

14.30-16.00 SO 01 PROGRESS IN BIPOLAR DISORDER
14.30-14.55 SO 0101 Treatment of mixed states
Eduard VIETA (Spain)
14.55-15.20 SO 0102 Treatment of bipolar depression
Alan YOUNG (United Kingdom)
15.20-15.45 SO 0103 Observational vs Randomised controlled studies
Rico NIL (Switzerland)
15.45-16.00 Discussion
16.00-16.30 Coffee break
16.30-18.00 SO 02 ADVANCES IN TREATMENT OF RESISTANT DEPRESSION
16.30-16.55 SO 0201 Should we stop raising the dose in nonresponders
Rasmus LICHT (Denmark)
16.55-17.20 SO 0202 Are two antidepressants better than one?
Michael BAUER (Germany)
17.20-17.45 SO 0203 Pharamacogentiecs in practice: are we close?
Alessandro SERRETTI (Italy)
17.45-18.00 Discussion
18.00-19.00 Opening Ceremony

09.00-10.30 SO 03 BROAD-SPECTRUM SYMPTOM CONTROL IN BIPOLAR DISORDER
WHAT ARE THE CHALLENGES?

Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S
10.30-11.00 Coffee break
11.00-12.30 SO 04 HOT TOPICS IN MOOD DISORDERS
11.00-11.25 SO 0401 Making sense in making guidelines
Karl BROICH (Germany)
11.25-11.50 SO 0402 Educational strategies for preventing suicide:
review of studies in Slovenia, Gotland and Germany
Saska ROSKAR (Slovenia)
11.50-12.15 SO 0403 Why do celebrities die young?
Borwin BANDELOW (Germany)
12.15-12.30 Discussion
12.30-13.30 Lunch
13.30-15.00 SO 05 OPTIMIZING TREATMENT OUTCOMES IN DEPRESSION
AND ANXIETY DISORDERS

Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S
15.00-16.00 SO 06 DEBATE: ANTIDEPRESSANT RESPONSE IS CLEARCUT
Pro: Elias ERIKSSON (Sweden)
Contra: Corrado BARBUI (Italy)
16.00-16.30 Coffee break
16.30-18.00 SO 07 NEGATIVE, COGNITIVE AND
DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIA
16.30-16.55 SO 0701 Depressive and negative symptoms –
are they really separate?
Hans-Juergen MOELLER (Germany)
16.55-17.20 SO 0702 New treatments for cognitive symptoms in schizophrenia
Raimund BULLER (France)
17.20-17.45 SO 0703 Treatment of affective or negative symptoms
of schizophrenia
Stefan LEUCHT (Germany)
17.45-18.00 Discussion

09.00-10.30 SO 08 COGNITIVE DYSFUNCTION OF DEPRESSION
A SYMPTOM THAT WE FAIL TO TREAT?
09.00-09.30 SO 0801 Current antidepressant treatments: what do we have and what do we need?
Philip COWEN (United Kingdom)
09.30-10.00 SO 0802 Assessing cognitive dysfunction in the depressed patient
Barbara SAHAKIAN (United Kingdom)
10.00-10.30 SO 0803 Review of current evidence for treatment
of cognitive dysfunction of depression
Siegfried KASPER (Austria)
Symposium sponsored by an unrestricted educational grant from H. Lundbeck A/S
10.30-11.00 Coffee break
11.00-12.30 SO 09 DEVELOPMENTS IN THE TREATMENT
OF ANXIETY DISORDERS
11.00-11.25 SO 0901 Sexual Disorders and OCD
Jose MENCHON (Spain)
11.25-11.50 SO 0902 Is hoarding a separate disorder?
Stefano PALLANTI (Italy)
11.50-12.15 SO 0903 Long term treatment of anxiety disordersand OCD
David BALDWIN (United Kingdom)
12.15-12.30 Discussion
12.30-13.30 Lunch
13.30-15.00 SO 10 NEW TARGETS FOR DEPRESSION
13.30-13.55 SO 1001 Are there new potential targets for depression?
Torgny SVENSSON (Sweden)
13.55-14.20 SO 1002 Neuroinflammation in MDD: current status and
treatment options
Johan den BOER (The Netherlands)
14.20-14.45 SO 1003 Cardiovascular outcome in MDD
Timothy DINAN (Ireland)
14.45-15.00 Discussion
15.00-16.30 SO 11 POETRY AND THE MEASUREMENT
OF DEPRESSION – A PERSONAL JOURNEY
Siegfried KASPER (Austria)
Stuart MONTGOMERY (United Kingdom)

 

Symposium sponsored by an unrestricted
educational grant from H. Lundbeck A/S